The Department of Cardiothoracic Surgery at Stanford University Medical Center takes pride in the rich tradition of excellence and pioneering firsts that have made it one of the top cardiac and thoracic programs in the nation. Our long and distinguished legacy of research dates back to the late 1950s — our most notable triumphs being the first adult human heart transplant in the United States, the world's first successful adult human combined heart-lung transplant, the first successful use of a ventricular device as a bridge to transplantation, the first thoracic aortic stent graft, and the development of the first integrated platform for minimally invasive heart surgery.
Our Department is comprised of three divisions:
Together, the Department of Cardiothoracic Surgery continues to improve patient health
through continual scientific innovation, revolutionary operative care, and exemplary surgical education.
Shudo Y, Cohen JE, Lingala B, He H, Woo YJ.
J Am Heart Assoc. 2018 Dec 4;7(23):e010253. doi: 10.1161/JAHA.118.010253.
The impact of donor obesity on the outcome of orthotopic heart transplantation has not been studied. The aim of this study was to investigate the impact of donor obesity on the outcomes of adult orthotopic heart transplantation recipients.
Department research, faculty prominently featured at the American Heart Association’s Scientific Sessions 2018
The American Heart Association (AHA) Scientific Sessions brings together nearly 13,000 physicians, surgeons, researchers, and healthcare professionals each year, serving as one of the world’s largest forums for the presentation and discussion of clinical innovations and research breakthroughs in cardiovascular medicine. At this year’s conference held in Chicago, IL, the Stanford Department of Cardiothoracic Surgery was prominently featured in 19 talks and poster presentations, showcasing a diverse spectrum of the department’s clinical expertise and research accomplishments.
The American Heart Association (AHA) Scientific Sessions were recently held November 10–12 in Chicago, IL. The AHA yearly sessions provide the most up-to-date research and a new dimension of cardiovascular discovery and clinical practice for clinicians, basic scientists, and researchers. Over 12,600 professional attendees including physicians, cardiology professionals, research scientists and other non-healthcare professionals from more than 100 countries attended and presented at this year's sessions.